Literature DB >> 23403604

Risk of pelvic inflammatory disease after Chlamydia infection in a prospective cohort of sex workers.

Bethan Davies1, Katy Turner, Helen Ward.   

Abstract

INTRODUCTION: There is uncertainty in the risk of pelvic inflammatory disease (PID) after chlamydia infection. We analyzed a prospective cohort of sex workers recruited in London between 1985 and 1993 to estimate the risk of PID after a diagnosed case of chlamydia.
MATERIALS AND METHODS: Chlamydia and gonorrhea were defined as "recent" if they occurred during the most recent 6 months of follow-up or "previous" if they were more than 6 months ago, were the second infection during follow-up, or occurred before the study. Pelvic inflammatory disease was diagnosed using clinical criteria. We used Cox proportional hazards regression to estimate the association between chlamydia and PID controlled for gonorrhea.
RESULTS: Three hundred seven women contributed 401.2 person-years of follow-up. The rate of PID in women with recent chlamydia was 27.4 per 100 person-years compared with 11.2 in those without recent chlamydia. Recent and previous chlamydia significantly increased the risk of PID; this association persisted but was no longer significant after controlling for age and history of gonorrhea: recent chlamydia (adjusted hazard ratio [aHR], 2.0; 95% confidence interval [CI], 0.7-5.5), previous chlamydia (aHR, 1.8; 95% CI, 1.0-3.5), previous gonorrhea (aHR, 2.3; 95% CI, 1.1-4.6), and age (HR, 0.9; 95% CI, 0.9-1.0). DISCUSSION: Women with recent or previous chlamydia are at increased risk for PID. However, this association may be explained by previous exposure to gonorrhea, which was found to increase the risk of PID after a future chlamydia infection.

Entities:  

Mesh:

Year:  2013        PMID: 23403604     DOI: 10.1097/OLQ.0b013e31827b9d75

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  5 in total

Review 1.  Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges.

Authors:  Andreea Waltmann; Tyler R McKinnish; Joseph A Duncan
Journal:  Curr Opin Infect Dis       Date:  2021-02-01       Impact factor: 4.915

2.  Bioluminescence imaging of Chlamydia muridarum ascending infection in mice.

Authors:  Jessica Campbell; Yumeng Huang; Yuanjun Liu; Robert Schenken; Bernard Arulanandam; Guangming Zhong
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

3.  Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease.

Authors:  Sung Taek Park; Suk Woo Lee; Min Jeong Kim; Young Mo Kang; Hye Min Moon; Chae Chun Rhim
Journal:  BMC Womens Health       Date:  2017-01-13       Impact factor: 2.809

4.  Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice.

Authors:  Roshan Pais; Yusuf Omosun; Qing He; Uriel Blas-Machado; Carolyn Black; Joseph U Igietseme; Kohtaro Fujihashi; Francis O Eko
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

5.  Hospitalisations for pelvic inflammatory disease temporally related to a diagnosis of Chlamydia or gonorrhoea: a retrospective cohort study.

Authors:  Joanne Reekie; Basil Donovan; Rebecca Guy; Jane S Hocking; Louisa Jorm; John M Kaldor; Donna B Mak; David Preen; Sallie Pearson; Christine L Roberts; Louise Stewart; Handan Wand; James Ward; Bette Liu
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.